> ## Documentation Index
> Fetch the complete documentation index at: https://markers.iollo.com/llms.txt
> Use this file to discover all available pages before exploring further.

# Methylmalonic Acid (MMA)

Methylmalonic Acid (MMA) is a marker of vitamin B12 deficiency. High levels of MMA can indicate a deficiency of vitamin B12, which can cause anemia and neurological problems.

## iollo markers that associate with Methylmalonic Acid (MMA)

### Isoleucine

Isoleucine, like valine, is metabolized to propionyl-CoA and methylmalonyl-CoA. Elevated isoleucine can occur alongside increased MMA when this pathway is disrupted.

<Accordion title="References">
  Rubio, V. G., & Acosta, P. B.. Variable dietary management of methylmalonic acidemia. *Molecular Genetics and Metabolism* (2011). [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001598/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001598/)

  van der Ham, I. N., et al.. Methylmalonic acid, vitamin B12, renal function, and risk of all-cause mortality: a population-based cohort study. *BMC Medicine* (2020). [https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01853-x](https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-020-01853-x)

  Berry, L. E., et al.. Impact on Isoleucine and Valine Supplementation When Decreasing Use of Medical Food in the Nutritional Management of Associated Disorders. *Nutrients* (2020). [https://www.mdpi.com/2072-6643/12/2/473](https://www.mdpi.com/2072-6643/12/2/473)

  Lee, W. M.. Brief Overview of Methylmalonic Acidemia. *Medscape Reference* (2022). [https://emedicine.medscape.com/article/1161799-overview](https://emedicine.medscape.com/article/1161799-overview)

  Zhang, S., et al.. Amino acid metabolism in health and disease. *Nature Reviews Molecular Cell Biology* (2023). [https://www.nature.com/articles/s41392-023-01569-3](https://www.nature.com/articles/s41392-023-01569-3)
</Accordion>

### Methionine

Methionine is a precursor to S-adenosylmethionine, a key methyl donor required for the conversion of methylmalonyl-CoA to succinyl-CoA. Impaired methionine metabolism can contribute to MMA accumulation.

<Accordion title="References">
  ScienceDirect Topics. Methylmalonic Acid - an overview. *ScienceDirect* (2024). [https://www.sciencedirect.com/topics/nursing-and-health-professions/methylmalonic-acid](https://www.sciencedirect.com/topics/nursing-and-health-professions/methylmalonic-acid)

  The Journal of Obstetrics and Gynaecology Research. Late-onset methylmalonic acidemia and homocysteinemia (cblC disease). *Obstetrics and Gynecology Research* (2024). [https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03021-3](https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03021-3)

  PMC. Methylmalonic acidemia: Current status and research priorities. *PMC* (2018). [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982627/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5982627/)

  Nature. A critical reappraisal of dietary practices in methylmalonic acidemia. *Nature* (2015). [https://www.nature.com/articles/gim2015107](https://www.nature.com/articles/gim2015107)

  NCBI. Methylmalonic acid, vitamin B12, renal function, and risk of all-cause mortality: a prospective cohort study. *NCBI* (2020). [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726887/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726887/)
</Accordion>

### Propionylcarnitine

Propionylcarnitine is derived from propionyl-CoA, a precursor of methylmalonyl-CoA in the metabolic pathway that leads to MMA formation. Elevated propionylcarnitine is a strong indicator of a block in this pathway causing MMA buildup.

<Accordion title="References">
  "S. M. Vockley, J. L. Hoppel, J. L. Kronn, S. A. Schneider, J. R. Shankaran, M. M. Zytkovicz". "Elevated methylmalonic acidemia (MMA) screening markers in newborn screening: Association of MMA screening markers with gestational age and birth weight". *"Molecular Genetics and Metabolism Reports"* (2018). [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361520/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361520/)

  "J. L. Hoppel, S. M. Vockley, J. L. Kronn, S. A. Schneider, J. R. Shankaran, M. M. Zytkovicz". "Biomarkers for drug development in propionic and methylmalonic acidemias". *"Molecular Genetics and Metabolism"* (2022). [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303879/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303879/)

  "S. A. Schneider, J. L. Hoppel, J. L. Kronn, S. M. Vockley, J. R. Shankaran, M. M. Zytkovicz". "Methylmalonic acidemia/propionic acidemia - the biochemical and clinical aspects". *"Orphanet Journal of Rare Diseases"* (2019). [https://ojrd.biomedcentral.com/articles/10.1186/s13023-019-1045-1](https://ojrd.biomedcentral.com/articles/10.1186/s13023-019-1045-1)
</Accordion>

### Succinic acid

Succinic acid is formed from succinyl-CoA, the product of the methylmalonyl-CoA pathway. Decreased succinic acid may be observed when the pathway is blocked, causing elevated MMA.

<Accordion title="References">
  S. Verbeke, E. De Roo, E. Van Puyvelde, et al.. "Serum methylmalonic acid concentrations at breast cancer diagnosis and their association with clinical frailty and survival in older patients". *European Journal of Cancer* (2023). [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10828366/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10828366/)
</Accordion>

### Valine

Valine is metabolized to propionyl-CoA and subsequently methylmalonyl-CoA. Impairment in the methylmalonyl-CoA pathway can lead to both elevated valine and MMA levels.

<Accordion title="References">
  S. Kruger, M. L. Brusius, A. R. Hoffmann, H. A. Grünert, and J. Kohlmüller. Isolated methylmalonic acidemias (MMA) - PMC - NCBI. *Medical foods for methylmalonic and propionic acidemias (MMA/PA) contain minimal valine, isoleucine, methionine and threonine, but have been used in MMA/PA treatment for decades.* (2016). [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752925/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752925/)

  A. J. Vockley, S. Kahler, M. L. Ensenauer, M. J. Leonard, J. N. Bennett, M. L. Burton, M. J. Church, J. L. Hoppel, J. M. Kronn, L. M. Mitchell, M. Mori, C. A. Niss, S. J. Piccolo, M. J. Puffenberger, S. Rhead, S. R. Rinaldo, A. E. Tuchman, and W. J. Valentine. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemias (MMA/PA). *Orphanet Journal of Rare Diseases* (2014). [https://ojrd.biomedcentral.com/articles/10.1186/s13023-014-0130-8](https://ojrd.biomedcentral.com/articles/10.1186/s13023-014-0130-8)

  J. A. D. M. van der Walt, M. A. van Kuilenburg, M. C. J. van Rij, and J. M. A. Boon. Methylmalonic acid, vitamin B12, renal function, and risk of all-cause mortality. *PLOS ONE* (2020). [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726887/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726887/)

  M. A. M. van Kuilenburg, J. A. D. M. van der Walt, and J. M. A. Boon. Methylmalonic acid levels in serum, exosomes, and urine: A systematic literature review and meta-analysis. *Frontiers in Neurology* (2022). [https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.1090958/full](https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2022.1090958/full)
</Accordion>
